Cargando…
Preclinical Models of Pediatric Brain Tumors—Forging Ahead
Approximately five out of 100,000 children from 0 to 19 years old are diagnosed with a brain tumor. These children are treated with medication designed for adults that are highly toxic to a developing brain. Those that survive are at high risk for a lifetime of limited physical, psychological, and c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315787/ https://www.ncbi.nlm.nih.gov/pubmed/30279402 http://dx.doi.org/10.3390/bioengineering5040081 |